Group A Meningococcal Polysaccharide Vaccine and Course of the Group A Meningococcal Epidemic in Finland
- 28 February 1978
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 10 (1), 41-44
- https://doi.org/10.3109/inf.1978.10.issue-1.09
Abstract
A group A meningococcal epidemic started in Finland in 1973 and had its peak in 1974. Its rapid decline and end after large scale vaccinations in 1975–76, involving approximately one quarter of the population, is described. It gives further proof of the clinical efficacy of the group A polysaccharide vaccine. No corresponding increase in the other serogroups has been seen in the 1½ years elapsed after these vaccinations.This publication has 13 references indexed in Scilit:
- Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of AgeNew England Journal of Medicine, 1977
- Polysaccharide Vaccines of Group A Neisseria meningitidis and Haemophilus influenzae Type b: A Field Trial in FinlandThe Journal of Infectious Diseases, 1977
- An Epidemic due to Sulphonamide-resistant Group A Meningococci in the Helsinki Area (Finland): Epidemiological and Clinical ObservationsScandinavian Journal of Infectious Diseases, 1976
- Vaccination against Meningococcal Group A Disease in Finland 1974–75Scandinavian Journal of Infectious Diseases, 1976
- Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.Journal of Clinical Investigation, 1975
- AN OUTER MEMBRANE PROTEIN OF NEISSERIA MENINGITIDIS GROUP B RESPONSIBLE FOR SEROTYPE SPECIFICITYThe Journal of Experimental Medicine, 1974
- DISEASE PREVENTION BY MENINGOCOCCAL SEROGROUP C POLYSACCHARIDE VACCINE IN PRESCHOOL CHILDREN: RESULTS AFTER ELEVEN MONTHS IN SAO PAULO, BRAZILPediatric Research, 1974
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969